0001179110-21-010539.txt : 20211202 0001179110-21-010539.hdr.sgml : 20211202 20211202171546 ACCESSION NUMBER: 0001179110-21-010539 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211130 FILED AS OF DATE: 20211202 DATE AS OF CHANGE: 20211202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BILBREY JOHN P CENTRAL INDEX KEY: 0001268386 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 211467760 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 825497352 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 4 1 edgar.xml FORM 4 - X0306 4 2021-11-30 0 0001739104 Elanco Animal Health Inc ELAN 0001268386 BILBREY JOHN P C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 1 0 0 0 Common Stock 2021-11-30 4 A 0 7307 0 A 21208 D Common Stock 24222 I Revocable Trust Deferred Stock Units 2021-11-30 4 A 0 307.3532 28.74 A Common Stock 307.3532 8205.1431 D Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021. /s/ Catherine Powell, as Attorney-in-Fact for John P. Bilbrey 2021-12-02